It appears that the central axis of CLL pathogenesis is the BCR signalling pathway, which promotes CLL cell survival and proliferation through downstream effectors such as PI3K and NF-κB [177]. This evidence concerns the gene NFKB1 and B-cell chronic lymphocytic leukemia.